BioNTech extends COVID-19 vaccine trial in China to end-October - CNA

5/10/2022 12:00:00 AM2 years 11 months ago

BEIJING: Vaccine developer BioNTech has extended by six months to October a Phase II clinical trial of its COVID-19 vaccine in China, a registry of such trials showed. The vaccine, based on messenger RNA (mRNA) technology, is one of the most widely used wo…

BEIJING: Vaccine developer BioNTech has extended by six months to October a Phase II clinical trial of its COVID-19 vaccine in China, a registry of such trials showed. The vaccine, based on messenge… [+774 chars]

full article...